The recent study highlights that while elevated levels of urinary NGAL and L-FABP are observed in DKD patients, these biomarkers are also increased in various non-diabetic CKD conditions, such as hypertensive nephrosclerosis and glomerulonephritis. The gene discussed is LCN2; the disease is diabetic kidney disease.